Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Bioinformatics Postdoctoral Fellow in Neuroscience Lab - Rockefeller University

    Description:

    The Greengard laboratory (Rockefeller University, New York, USA) is accepting applications from outstanding individuals for a 2-3 year postdoctoral research fellowship in the field of bio-informatics and/or applied mathematics. The position is available immediately.
    The candidate should have a PhD in the field of bio-informatics or applied mathematics, ideally with some experience in biology related questions. The candidate should already be familiar with gene expression data analysis, preferably with RNA-seq data analysis. Proficiency in Linux scripting, in a major programming language and in handling large datasets are a must.
    The successful candidate will have the opportunity to collaborate with a team of biologists (molecular biologists, biochemists and behavior specialists) as well as to pursue unique research in the fields of system biology, neurodegeneration (e.g. Alzheimer’s disease and Parkinson’s disease) and other brain related disorders such as major depression. This position requires a highly self-motivated individual with excellent oral communication skills and great interpersonal skills. Interested candidates should send an updated CV, together with the names and the contact information for three professional references and a description of their work interest to:
    [email protected]

    Employer:

    Rockefeller University has a long history of outstanding scientific research. The Greengard laboratory is renowned for its work on neuronal signaling, both in normal and pathological conditions including various disorders such as Alzheimer’s disease, Parkinson’s disease and major depression. Recently, the laboratory, in collaboration with Dr. Heintz (Rockefeller University, New York, USA), developed a novel powerful technology called bacTRAP (Heiman et al., Cell, 2008, Doyle et al., Cell, 2008), aimed at isolating translated mRNAs from specific neuronal populations across the brain. This technology, coupled to RNA-sequencing, yields an extremely detailed and unprecedented insight into these intricate neuronal populations, otherwise inaccessible.

    Project:

    Our laboratory is now applying this technology to study various disorders and neurodegenerative diseases. The goal, for Alzheimer’s Disease for example, is the characterization of degenerating cells in mouse models. Gene expression data for neurons susceptible to degeneration, in young adult mice, in aged mice, and in the context of different perturbations are being generated. In order to translate these highly extensive datasets into knowledge, the candidate will apply the latest existing analysis tools from the RNA-seq field, and will be encouraged to search and/or develop new ones. The candidate will search for the molecular factors/pathways most associated with pathological conditions, in close collaboration with the other scientists involved. The candidate will also have the possibility to design her/his own project aimed at understanding the structure of all the studied translatomes, by studying the joint datasets generated for the various individual projects. Because of the novelty of the bacTRAP technology, there is a high potential for new therapeutic target discovery for Alzheimer’s disease, Parkinson’s disease, major depression and for more fundamental discoveries as well. Because the candidate will be integrated into a team of skilled neurobiologists, biochemists and molecular biologists, her/his project will not be of an abstract modeling nature. He will be constantly in touch with the actual biology of the brain. In silico findings will be verified in functional experiments that the lab has proven great expertise for, over the years, thus making this bio-informatics project a very concrete rewarding one.

Latest Articles

Collapse

  • seqadmin
    Advancing Precision Medicine for Rare Diseases in Children
    by seqadmin




    Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...
    12-16-2024, 07:57 AM
  • seqadmin
    Recent Advances in Sequencing Technologies
    by seqadmin



    Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.

    Long-Read Sequencing
    Long-read sequencing has seen remarkable advancements,...
    12-02-2024, 01:49 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 12-17-2024, 10:28 AM
0 responses
32 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-13-2024, 08:24 AM
0 responses
48 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-12-2024, 07:41 AM
0 responses
34 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-11-2024, 07:45 AM
0 responses
46 views
0 likes
Last Post seqadmin  
Working...
X